Search results
Results From The WOW.Com Content Network
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, [3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs.
The merged entity was then named as Zydus Wellness Limited in January 2009. [12] [13] In 2009, the company began manufacturing men's grooming and skincare products. [12] [14] In 2011, Zydus Wellness launched its milk additive brand Actilife. [15] In 2017, Zydus Wellness developed stevia products as part of its sugar substitute business. [16]
Zydus Lifesciences and Sun Pharmaceuticals have entered an agreement in October 2023 to co-market Desidustat. Sun Pharma will sell the drug as Rytstat , while Zydus will continue to sell it as Oxemia . [ 17 ]
For example, Zydus Lifesciences and Intas Pharmaceuticals one of the largest pharmaceutical companies in Gujarat, has a state-of-the-art R&D facility in Ahmedabad. [47] [48] Similarly, Torrent Pharmaceuticals has a dedicated R&D centre in Gandhinagar. [49] [50]
He took charge in 1995 after a formal separation between the two founding families from Zydus Cadila to Zydus Lifesciences and Cadila Healthcare. [7] When he took over the Cadila Healthcare, he was faced with two challenges: His was a Rs 200-crore company whereas his overheads including management, research, company expenses, and staff worked ...
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. [1] India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports.
Epalrestat is a carboxylic acid derivative [1] and a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy, which is one of the most common long-term complications in patients with diabetes mellitus.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us